Health Canada approves Pfzier vaccine for children aged 5-11
OTTAWA – Health Canada has approved the first COVID-19 vaccine for children aged five to 11 in Canada.
Pfizer and its partner BioNTech submitted a request for approval of a child-sized dose of its mRNA vaccine for COVID-19 on Oct. 18.
The companies say the results of their trials in children show comparable safety and efficacy results to those recorded in a previous Pfizer-BioNTech study in adults aged 16 to 25.
Health Canada said it would only approve the vaccine for children if its analysis showed the benefits outweigh the potential risks.